Stock Comparison
NBIX vs TEVA
Neurocrine Biosciences Inc and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$16.94B
$38.67B
P/E (TTM)
25.9
24.8
Forward P/E
23.2
16.0
Price/Sales
5.5
2.2
Price/Book
4.9
4.7
EV/EBITDA
18.8
16.3
Dividend Yield
—
—
Profitability
Net Margin
21.50%
9.02%
Operating Margin
22.80%
19.20%
Return on Equity
22.50%
21.60%
Return on Assets
11.60%
6.38%
Growth (YoY)
Revenue Growth
42.20%
2.30%
Earnings Growth
2311.00%
72.20%
Price & Risk
Beta
0.4
0.9
52-Week High
$169.57
$37.35
52-Week Low
$122.14
$14.99
Analyst Target
$194.38
$40.90
Compare NBIX and TEVA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.